Ref: PHE publications gateway number 2017126PDF, 1.18MB, 84 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email firstname.lastname@example.org.
Please tell us what format you need. It will help us if you say what assistive technology you use.
The guidance has been developed to aid the public health management of hepatitis A infection which aims to reduce the occurrence of secondary infections and to prevent and control outbreaks.
The guidance has been developed based on a review of the current epidemiology of hepatitis A in England and a review of the literature on the efficacy of human normal immunoglobulin (HNIG) and hepatitis A vaccine for post-exposure prophylaxis. This guidance updates the 2009 Guidance for the Prevention and Control of Hepatitis A Infection.
The documents on temporary recommendations during supply constraints have been removed as there is currently no supply shortage.